Skip to content

Axogen AXGN Return on equity

Return on equity at other companies

Baxter International logo
Baxter InternationalBAX
-16.7%-76.7pp
LeMaitre Vascular logo
LeMaitre VascularLMAT
16.5%+2.8pp
Medtronic logo
MedtronicMDT
9.8%+0.4pp

Other financials

Income statement

See full
Revenue$61.5M+26.6%
Gross profit$46.2M+32.2%
Operating income-$2.8M-70.5%
Net income-$19.6M-411%
EPS (diluted)-$0.38-375%

Balance sheet

See full
Cash & equivalents$84.7M+251%
Total debt$20.6M-69.8%
Total equity$244.8M+132%
Total assets$289.5M+47.6%

Cash flow

See full
Operating cash flow$1.6M+112%
CapEx$2.8M+989%
Free cash flow-$1.2M+90.9%

Valuation

See full
Market cap$2.38B+110%
Enterprise value$2.31B+91.4%
P/S10×+4.2×

Profitability

See full
Gross margin75%+0.8pp
Operating margin-3.8%
Net margin-13.2%-22.8pp
FCF margin-12.9%-3.8pp

Returns & leverage

See full
Debt / equity0.1×-0.6×
Current ratio7.1×+2.8×

Where this comes from

Calculated from Axogen’s reported figures.

Based on trailing twelve months.

The official record: Axogen’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Axogen's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Axogen's return on equity?
Axogen (AXGN) reported return on equity of -18% in Q1 2026.
How has Axogen's return on equity changed year-over-year?
Axogen's return on equity decreased by 134.2% year-over-year, from -7.7% to -18%.
What is the long-term trend for Axogen's return on equity?
Over 5 years (2020 to 2025), Axogen's return on equity has grown at a -6.3% compound annual growth rate (CAGR), from -18.6% to -13.5%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.